multiplesclerosisnewstoday....
Nice to see the research continuing to report positive findings in both RRMS and PPMS. While it is still early days for this particular B-cell depleting therapy, my neurologist said that based on what is known so far, the general expectation is for Ocrevus to become a leading front-line treatment recommendation for MS, and possibly "the" leading treatment.
Time will tell.